David Robbins

Robbins is a co-founder of Trevi Health Capital (in which capacity he serves as CIO). After beginning his career as a corporate lawyer at Cahill Gordon & Reindel, he served as a strategic advisor to Elan Corporation, plc and as an advisor to the board of directors of Barr Pharmaceuticals in connection with the formation of Commerce Health Ventures, a healthcare investment fund in which he later served as a partner. Mr. Robbins serves as a board member of Trevi portfolio companies Paradigm Spine, Optovue and Home Skinovations, as well as Bally Technologies, Inc. (NYSE Arca: BYI), a diversified gaming and technology company, and previously Medisys plc; and is chairman of the board of trustees of the McCarton Foundation and School (addressing autism and developmental disabilities) and a member of the steering committee for the NYU Langone Comprehensive Epilepsy Center. He previously served as a board member for Columbia University Medical School's Science and Technology Council and Connecticut Innovations life sciences seeder fund. Mr. Robbins has served as an assistant adjunct professor at the Benjamin N. Cardozo Law School, where he has taught courses in corporate finance. Mr. Robbins is a graduate of the Wharton School of the University of Pennsylvania, magna cum laude, and New York University School of Law.